DuPont de Nemours, Inc. (DD) Q2 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
DuPont's earnings call indicates a positive sentiment with strong growth expectations in healthcare and water, a well-positioned electronics segment, and a strategic focus on M&A in fragmented markets. The Qnity spin-off and effective tariff mitigation further boost confidence. Despite some uncertainties, such as the Aramids divestment, the overall outlook is optimistic, suggesting a positive stock price movement.
Key Financial Performance
Second Quarter Sales $3.3 billion, grew 2% on an organic basis year-over-year. Growth driven by strength in Electronics (AI technology demand) and Healthcare & Water, offset by weakness in construction.
Operating EBITDA $859 million, increased 8% year-over-year. Margin improved to 26.4%, up 120 basis points. Growth attributed to organic sales growth and productivity benefits.
Adjusted EPS $1.12, up 15% year-over-year from $0.97. Increase driven by higher segment earnings and a lower tax rate.
Transaction-Adjusted Free Cash Flow $433 million with a conversion rate of 93%. Performance aligned with expected acceleration.
ElectronicsCo Net Sales $1.2 billion, increased 6% year-over-year. Growth driven by an 8% increase in volume, partially offset by a 2% price decrease. Strong demand in semiconductor technologies and AI-driven applications.
ElectronicsCo Operating EBITDA $373 million, up 14% year-over-year. Margin improved to 31.9%, up 220 basis points. Growth supported by organic sales and lower legal costs.
IndustrialsCo Net Sales $2.1 billion, up 1% year-over-year. Growth driven by 2% volume increase, offset by a 1% price decline. Healthcare & Water sales grew high single digits, while Diversified Industrial sales declined due to construction market softness.
IndustrialsCo Operating EBITDA $509 million, up 3% year-over-year. Margin improved to 24.4%, up 50 basis points. Growth supported by organic sales and productivity gains.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
AI technology demand: Continued strength in Electronics driven by AI technology demand in Interconnect Solutions and semi.
Healthcare & Water: Strong volume growth in Healthcare & Water technologies.
Asia Pacific: Delivered 4% organic sales growth year-over-year.
Europe: Organic sales were up 2%.
North America: Organic sales were up 1%.
Operating EBITDA: Increased 8% year-over-year to $859 million, with a margin of 26.4%, up 120 basis points.
Adjusted EPS: Increased 15% year-over-year to $1.12.
Free Cash Flow: Transaction-adjusted free cash flow of $433 million with a conversion rate of 93%.
Qnity Electronics Spin-off: Progress on the intended spin-off of Qnity Electronics remains on track for a November 1 separation date. The Qnity Board has been finalized with 10 members.
Settlement with New Jersey: Announced a $177 million settlement to resolve environmental claims, payable over 25 years.
Leadership Changes: New senior leadership team assembled for the New DuPont, including Jeroen Bloemhard, Beth Ferreira, and David Cook.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Weakness in construction markets: Continued softness in construction markets negatively impacted the diversified industrials business, leading to low single-digit declines in sales.
Environmental claims settlement: The company announced a $177 million settlement to resolve environmental claims, including PFAS, which will be payable over 25 years. This represents a financial burden and potential reputational risk.
Tariff impacts: Tariffs are expected to create a $20 million headwind in the second half of 2025, impacting earnings by $0.04 per share.
Delayed recovery in construction end markets: The delayed recovery in construction end markets is contributing to volume softness, affecting the company's financial performance.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Full Year Earnings Guidance: The company is raising its full year earnings guidance due to strong second quarter financial performance.
Separation of Qnity Electronics: The spin-off of Qnity Electronics is on track for a November 1, 2025 separation date. The Qnity Board has been finalized, and the company is preparing for an Investor Day on September 18 to introduce the portfolios and strategies of both DuPont and Qnity.
Future of Qnity Electronics: Qnity Electronics is positioned as a pure-play technology solutions leader within the semiconductor value chain, with growth driven by AI applications, high-performance computing, and advanced connectivity. The company expects a large and expanding addressable market with multiple industry tailwinds.
2025 Financial Guidance: The midpoint of full year total company net sales guidance remains at $12.85 billion. Operating EBITDA guidance is raised to $3.36 billion, and adjusted EPS guidance is raised to $4.40 per share. The guidance incorporates a $20 million tariff headwind in the second half of 2025.
Third Quarter 2025 Guidance: Net sales are estimated at $3.32 billion, operating EBITDA at $875 million, and adjusted EPS at $1.15 per share. Organic sales growth of about 3% is expected, led by healthcare, water, and electronics end markets, with continued weakness in construction end markets.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:What is the reason behind the 1% price reduction in the industrials segment?
A:The price reduction is related to the price increases taken during the inflationary period and the need to give back some of it as the raw material environment resolved. It is more related to the diversified industrial space and not the tieback or healthcare space.
Q:Will there be efforts to capture price to offset tariff impacts?
A:The majority of the reduction is related to supply chain moves to avoid tariffs. There are some surcharges to offset, but the gross headwind has been reduced to a $20 million net headwind.
Q:What is the significance of the AFFF settlement and its implications for future settlements?
A:The AFFF settlement amount was 1% of the total settlement and aligns with the original water district settlement case, where 3% to 7% of the total headwind belongs to DuPont. Future settlements in states without a site are expected to fall within this range. The settlement is paid over 25 years, minimizing cash flow impact.
Q:How did Healthcare & Water perform, and what are the expectations for the back half of the year?
A:Both segments were up high single digits, with healthcare slightly ahead of water. The destocking in RO and medical packaging has been lapped, and both segments are expected to show outsized growth in the back half of the year due to secular trends like clean water access and an aging population.
Q:Are there any pressures from Medicaid or Medicare reimbursements in the healthcare business?
A:No, there are no such pressures in the healthcare business.
Q:What is the current state of the electronics market, and how is DuPont positioned?
A:The electronics market is mixed, with growth driven by AI applications in advanced nodes, packaging, and data centers. Consumer markets remain weak, but stabilization and recovery are expected in lagging edge parts. DuPont is well-positioned in advanced technologies and data centers.
Q:What is the impact of changes in chip assembly and manufacturing processes on DuPont's content?
A:DuPont is well-positioned to address changes in chip assembly and manufacturing processes due to its strong position in advanced packaging and its ability to collaborate with customers on end-to-end manufacturing processes.
Q:What are the growth expectations for semi-advanced packaging and ICS in the second half of the year?
A:Growth is expected to be driven by hyperscalers, node migrations (e.g., N2 and HBM), and broader market recovery in industrial and consumer markets. DuPont is well-positioned with content gains in advanced nodes and DRAM.
Q:What are the drivers of high single-digit growth in Healthcare & Water?
A:Growth is driven by recovery from destocking, strong customer relationships, leading market positions, and secular trends in clean water and healthcare. DuPont has also regained share in China's RO market.
Q:What is the focus of DuPont's M&A strategy post-separation?
A:The focus is on building a pipeline of assets in healthcare and water, with an emphasis on fragmented markets and opportunities to bolster the portfolio.
Q:Why did organic sales growth in Interconnect Solutions slow in Q2?
A:The slowdown is due to year-over-year comparisons, as Q1 2024 had easier comps. Growth in Q2 was driven by AI and advanced packaging, and momentum is expected to continue.
Q:What is the rationale behind DuPont's agreement to buy rights and insurance proceeds from Chemours?
A:The agreement ensures Chemours has ample liquidity to make payments over the next 5 years, with confidence in recovering the insurance money.
Q:What is the significance of DuPont's exposure to China in electronics?
A:DuPont's exposure to China is driven by its strong position in printed circuit board and assembly manufacturing, as well as semiconductor fabs. The exposure is expected to normalize at around 30% of sales.
Q:What is the status of the Aramids divestment?
A:No comment was provided on the Aramids divestment. DuPont is focused on the Qnity separation and shifting the portfolio towards healthcare and water.
Q:How does the agreement with Chemours and Corteva impact potential divestments?
A:The minimum EBITDA requirements will be reset post-separation, providing cushion for potential divestments. Proceeds from divestments are expected to be redeployed in M&A.
Q:What is the margin outlook for IndustrialsCo in the second half of the year?
A:Margins are expected to remain strong, driven by productivity and volume growth. Pricing will be less of a drag, and the focus will be on balancing volume and price.
Q:What is the rationale for keeping the Water business in the portfolio?
A:The Water business is considered core to New DuPont, with plans to grow and invest in it due to its alignment with secular trends and strong market position.
Q:What are the mitigating factors for tariff impacts?
A:Mitigating factors include supply chain moves to avoid tariffs and some surcharges to offset impacts.
Q:What is the margin performance in ElectronicsCo, and what are the drivers?
A:Margins are healthy, driven by volume growth, productivity, and a favorable mix in advanced nodes and AI-driven applications.
Q:What is the significance of the suspension of the Chinese investigation into Tyvek?
A:The suspension and closure of the investigation into Tyvek is a positive outcome for DuPont, with no further investigations mentioned.
Q:Review of Unclear Management Responses
A:Management avoided providing a direct answer regarding the status of the Aramids divestment, stating no comment and focusing on the Qnity separation and portfolio shift towards healthcare and water.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
AFFF settlement
AG Frank
Bank
CEO
Capital Markets
Conference
DuPont portfolio
Electronics
Healthcare Water
Investor Day
New DuPont
PFAS
Patrick
President
Research LLC
SEC
Securities
Stephen
VP Investor
advantage
claim
customer
excellence
experience
industrials
industry
knowledge
leader
partner
play technology
semiconductor value
technology solution
track
value chain
DD Transcript
DuPont de Nemours, Inc. (DD) Q1 2026 Earnings Call Transcript
Unknown5-5
The earnings call summary presents mixed signals. Positive elements include strong margins, productivity gains, and strategic positioning in the healthcare and automotive segments. However, concerns arise from flat organic sales, construction market weakness, and uncertainties related to Middle East logistics. The Q&A section revealed management's avoidance of addressing potential demand destruction. These factors balance out, suggesting a neutral stock price reaction.
DuPont de Nemours, Inc. (DD) Q4 2025 Earnings Call Transcript
Positive2-10
The earnings call summary and Q&A session reveal strong financial metrics, optimistic guidance, and positive shareholder returns, including a $2 billion share repurchase plan. Despite some concerns about regional sales and margin details, the overall sentiment is positive with raised guidance and strategic initiatives like the reverse osmosis expansion in China. These factors suggest a likely positive stock price movement in the short term.
DuPont de Nemours, Inc. (DD) Q3 2025 Earnings Call Transcript
Positive11-6
The company raised its earnings guidance, announced a significant share repurchase plan, and demonstrated strong performance in key sectors like healthcare and water. The Q&A revealed operational excellence initiatives and a robust M&A pipeline, further supporting growth. Although there are some uncertainties, such as the timing benefit and construction market outlook, the overall sentiment is positive, with strong management confidence in achieving growth targets.
DuPont de Nemours, Inc. (DD) Q2 2025 Earnings Call Transcript
Positive8-5
DuPont's earnings call indicates a positive sentiment with strong growth expectations in healthcare and water, a well-positioned electronics segment, and a strategic focus on M&A in fragmented markets. The Qnity spin-off and effective tariff mitigation further boost confidence. Despite some uncertainties, such as the Aramids divestment, the overall outlook is optimistic, suggesting a positive stock price movement.
DD Slides
DD Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
